Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Drugs Health Services Research & Managerial Epidemiology

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

Read about how the publisher censored this paper by retracting it and how the authors sued to fight back: See the Assault on Science website and the Arbitration Demand.

Additional Author: Christopher Craver

Abstract

Introduction

Existing research on post abortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Post abortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures.

Objective

To complete the first longitudinal cohort study of post abortion emergency room use following chemical and surgical abortions.

Methods

A population-based longitudinal cohort study of 423 000 confirmed induced abortions and 121,283 subsequent ER visits occurring within 30 days of the procedure, in the years 1999-2015, to Medicaid-eligible women over 13 years of age with at least one pregnancy outcome, in the 17 states which provided public funding for abortion.

Results

ER visits are at greater risk to occur following a chemical rather than a surgical abortion: all ER visits (OR 1.22, CL 1.19-1.24); miscoded spontaneous (OR 1.88, CL 1.81-1.96); and abortion-related (OR 1.53, CL 1.49-1.58). ER visit rates per 1000 abortions grew faster for chemical abortions, and by 2015, chemical versus surgical rates were 354.8 versus 357.9 for all ER visits; 31.5 versus 8.6 for miscoded spontaneous abortion visits; and 51.7 versus 22.0 for abortion-related visits. Abortion-related visits as a percent of total visits are twice as high for chemical abortions, reaching 14.6% by 2015. Miscoded spontaneous abortion visits as a percent of total visits are nearly 4 times as high for chemical abortions, reaching 8.9% of total visits and 60.9% of abortion-related visits by 2015.

Conclusion

The incidence and per-abortion rate of ER visits following any induced abortion are growing, but chemical abortion is consistently and progressively associated with more post abortion ER visit morbidity than surgical abortion. There is also a distinct trend of a growing number of women miscoded as receiving treatment for spontaneous abortion in the ER following a chemical abortion.

 

Read Assaultonscience.org

Read Press Release

Read Complete Article

Latest Posts

May 26, 2026 A stylized white geometric design resembling a circular burst is centered over a dark blue map outline of the United States, highlighting the complexities of U.S. law and FDA safety limits around online abortion drug sellers. New CLI Report: Online Abortion Drug Sellers Violating U.S. Law and FDA Safety Limits May 26, 2026 A woman sits at a wooden table with a laptop and phone, gazing thoughtfully out a window. Sunlight filters through sheer curtains, and a green potted plant is beside her as she researches online abortion drug access in post-Dobbs America. An Overview of Online Abortion Drug Access in Post-Dobbs America May 26, 2026 A grayscale ultrasound image shows the side profile of a developing baby in the womb, with the head, torso, and limbs visible. Abortion Drugs Now Arrive As Fast As An Amazon Package

You Might Also Be Interested In

An orange prescription bottle labeled MISOPROSTOL, a common abortion pill, filled with yellow tablets sits in front of several white medicine bottles against a light blue background.

Induced Abortion with Misoprostol Alone

May 15, 2026
Please login to bookmark Close
A person sits on an unmade bed facing a bright window with sheer curtains, their silhouette outlined by the warm, orange glow of sunlight—evoking a moment of quiet reflection on abortion in the dimly lit room.

Reproductive Coercion and Abortion

May 14, 2026
Please login to bookmark Close
An orange pill bottle, scattered white pills, and an ultrasound photo strip rest on a textured pink fabric surface, symbolizing the experience of a medical abortion.

Drug-induced Abortion After the First Trimester

April 14, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image